PSTI Expression in Colorectal Cancer
Author Information
Author(s): M. Higashiyama, T. Monden, N. Tomita, M. Murotani, Y. Kawasaki, H. Morimoto, A. Murata, T. Shimano, M. Ogawa, T. Mori
Primary Institution: Osaka University School of Medicine
Hypothesis
Does pancreatic secretory trypsin inhibitor (PSTI) play a role in colorectal cancer development?
Conclusion
PSTI is commonly produced and expressed in colorectal cancer, particularly in more advanced cases.
Supporting Evidence
- 84% of colorectal cancer cases showed positive PSTI expression.
- PSTI expression was higher in well or moderately differentiated adenocarcinomas.
- The intensity of PSTI staining increased with tumor size and depth of invasion.
Takeaway
This study found that a protein called PSTI is often found in colorectal cancer, especially in larger and more invasive tumors.
Methodology
The study used immunohistochemical staining, in situ hybridization, and Northern blot hybridization to analyze PSTI expression in colorectal cancer tissues.
Limitations
The study's findings may not be generalizable due to the specific population and methods used.
Participant Demographics
The study involved 95 colorectal cancer cases, but specific demographic details were not provided.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website